Your browser doesn't support javascript.
loading
Polyoxypregnanes as safe, potent, and specific ABCB1-inhibitory pro-drugs to overcome multidrug resistance in cancer chemotherapy
Acta Pharmaceutica Sinica B ; (6): 1885-1902, 2021.
Article en En | WPRIM | ID: wpr-888840
Biblioteca responsable: WPRO
ABSTRACT
Multidrug resistance (MDR) mediated by ATP binding cassette subfamily B member 1 (ABCB1) is significantly hindering effective cancer chemotherapy. However, currently, no ABCB1-inhibitory drugs have been approved to treat MDR cancer clinically, mainly due to the inhibitor specificity, toxicity, and drug interactions. Here, we reported that three polyoxypregnanes (POPs) as the most abundant constituents of
Palabras clave
Texto completo: 1 Índice: WPRIM Idioma: En Revista: Acta Pharmaceutica Sinica B Año: 2021 Tipo del documento: Article
Texto completo: 1 Índice: WPRIM Idioma: En Revista: Acta Pharmaceutica Sinica B Año: 2021 Tipo del documento: Article